CN104306962A - 利用切割酶切割病毒转录酶方法 - Google Patents

利用切割酶切割病毒转录酶方法 Download PDF

Info

Publication number
CN104306962A
CN104306962A CN201410542060.6A CN201410542060A CN104306962A CN 104306962 A CN104306962 A CN 104306962A CN 201410542060 A CN201410542060 A CN 201410542060A CN 104306962 A CN104306962 A CN 104306962A
Authority
CN
China
Prior art keywords
nickase
transcriptase
cut
virus
retroviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410542060.6A
Other languages
English (en)
Inventor
郭和友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410542060.6A priority Critical patent/CN104306962A/zh
Publication of CN104306962A publication Critical patent/CN104306962A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明涉及一种利用切割酶切割病毒转录酶方法。目前公知的治疗病毒方法副作用大，不能定点清除。本发明的目的是；利用切割酶切割病毒转录酶.经过采集病毒的转录酶和转录病毒测序，后计算和定位内切酶识别序列来完成设计内切酶.切割酶包括有切割功能的内切酶，核酸酶等.运送到病灶可以采取局部注射方式和要治疗本身病毒去核改造为运输工具到达病灶。

Description

利用切割酶切割病毒转录酶方法
技术领域
本发明涉及一种利用切割酶切割病毒转录酶方法。 
技术背景
目前公知的治疗病毒方法副作用大，不能定点清除。 
发明内容
本发明的目的是；利用切割酶切割病毒转录酶. 
本发明的解决其技术问题采用的方案是；经过采集病毒的转录酶和转录病毒测序，后计算和定位内切酶识别序列来完成设计内切酶.内切酶通过运送体内内工具如去活性病毒进入体内对病毒的转录酶和转录病毒的点位进行切割.利用改造去毒的病毒为载体运送工具来运送设计好的切割酶.切割点位包膜和细菌序列.根据不同病毒来设计不同切割酶.再通过细胞自我修复使病人康复。进入体内对转录病毒和转录酶点位切割.切割酶包括有切割功能的内切酶，核酸酶等.运送到病灶可以采取局部注射方式和要治疗本身病毒去核改造为运输工具到达病灶。 
本发明的好处是；清除潜伏休眠病毒或细菌，副作用小，定点清除。 
下面结合附图对本发明作进一步说明 
图1是一种利用切割酶切割病毒转录酶方法 
图中1采集的转录酶和转录病毒测序 2计算和定位内切酶识别序列 3设计好的内切酶 4运送体内内工具 5去活性病毒 6进入体内对启动子及其他点位切割 7细胞自我修复 8康复在图1中 
经过采集的转录酶和转录病毒测序(1)，后计算和定位内切酶识别序列(2)完成设计好的切割酶(3)。设计好的切割酶(3)通过运送体内内工具(4)如去活性病毒(5)进入体内对启动子及其他点位切割(6)。再通过细胞自我修复使病人(7)康复(8)。 

Claims (4)

1.一种利用切割酶切割转录酶和转录病毒方法，其特征是；经过采集病毒的转录酶和转录病毒测序，后计算和定位内切酶识别序列来完成设计内切酶.内切酶通过运送体内内工具如去活性病毒进入体内对转录酶和转录病毒的点位进行切割。 
2.根据权利要求书(1)所述的一种利用切割酶切割转录酶和转录病毒方法，其特征是；利用改造去毒的病毒为载体运送工具来运送设计好的切割酶.运送病灶可以采取局部注射方式。运送到病灶可以采取局部注射方式和要治疗本身病毒去核改造为运输工具到达病灶。 
3.根据权利要求书(1)所述的一种利用切割酶切割转录酶和转录病毒方法，其特征是；切割点位包膜和细菌序列.根据不同病毒来设计不同切割酶.切割酶包括有切割功能的内切酶，核酸酶等。
4.根据权利要求书(1)所述的一种利用切割酶切割转录酶和转录病毒方法，其特征是；再通过细胞自我修复使病人康复。 
CN201410542060.6A 2014-10-05 2014-10-05 利用切割酶切割病毒转录酶方法 Pending CN104306962A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410542060.6A CN104306962A (zh) 2014-10-05 2014-10-05 利用切割酶切割病毒转录酶方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410542060.6A CN104306962A (zh) 2014-10-05 2014-10-05 利用切割酶切割病毒转录酶方法

Publications (1)

Publication Number Publication Date
CN104306962A true CN104306962A (zh) 2015-01-28

Family

ID=52362371

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410542060.6A Pending CN104306962A (zh) 2014-10-05 2014-10-05 利用切割酶切割病毒转录酶方法

Country Status (1)

Country Link
CN (1) CN104306962A (zh)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024530A1 (de) * 1990-08-02 1992-02-06 Klinger & Co Dr Verfahren zur bekaempfung von viren
WO1993020207A1 (en) * 1992-04-02 1993-10-14 The United States Of America, As Represented By The Secretary Of Health And Human Services Use of restriction endonucleases against viruses, including hiv
WO1996022368A1 (en) * 1995-01-18 1996-07-25 Gene Shears Pty. Ltd. Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
EP0979655A1 (de) * 1998-08-01 2000-02-16 Boehringer Mannheim Gmbh Mittel zur Behandlung von durch RNA-Viren, wie beispielsweise HIV verursachten Infenktionen
WO2001094391A2 (en) * 2000-06-08 2001-12-13 Incyte Genomics, Inc. Intracellular signaling proteins
CN1364898A (zh) * 2002-02-05 2002-08-21 中国人民解放军第四军医大学 治疗乙肝病毒感染的靶向核糖核酸酶的制备工艺
CN1490050A (zh) * 2002-10-17 2004-04-21 中国医学科学院医学生物学研究所 甲型肝炎灭活疫苗
CA2549663A1 (en) * 2005-06-06 2006-12-06 University Of Northern British Columbia Endoribonuclease and uses thereof
CN1906292A (zh) * 2003-11-21 2007-01-31 新英格兰生物实验室公司 修饰的dna切割酶和其应用方法
CN1927399A (zh) * 2006-09-26 2007-03-14 复旦大学 非核苷类抑制病毒逆转录酶化合物及其衍生物在抗乙肝病毒中的应用
CN101250510A (zh) * 2008-03-19 2008-08-27 广东药学院 丙肝病毒特异性核酶M1GS-hcv/C20的构建方法和应用

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4024530A1 (de) * 1990-08-02 1992-02-06 Klinger & Co Dr Verfahren zur bekaempfung von viren
WO1993020207A1 (en) * 1992-04-02 1993-10-14 The United States Of America, As Represented By The Secretary Of Health And Human Services Use of restriction endonucleases against viruses, including hiv
US5523232A (en) * 1992-04-02 1996-06-04 The United States Of America As Represented By The Department Of Health And Human Services Use of restriction endonucleases against viruses, including HIV
WO1996022368A1 (en) * 1995-01-18 1996-07-25 Gene Shears Pty. Ltd. Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
EP0979655A1 (de) * 1998-08-01 2000-02-16 Boehringer Mannheim Gmbh Mittel zur Behandlung von durch RNA-Viren, wie beispielsweise HIV verursachten Infenktionen
WO2001094391A2 (en) * 2000-06-08 2001-12-13 Incyte Genomics, Inc. Intracellular signaling proteins
CN1364898A (zh) * 2002-02-05 2002-08-21 中国人民解放军第四军医大学 治疗乙肝病毒感染的靶向核糖核酸酶的制备工艺
CN1490050A (zh) * 2002-10-17 2004-04-21 中国医学科学院医学生物学研究所 甲型肝炎灭活疫苗
CN1906292A (zh) * 2003-11-21 2007-01-31 新英格兰生物实验室公司 修饰的dna切割酶和其应用方法
CA2549663A1 (en) * 2005-06-06 2006-12-06 University Of Northern British Columbia Endoribonuclease and uses thereof
CN1927399A (zh) * 2006-09-26 2007-03-14 复旦大学 非核苷类抑制病毒逆转录酶化合物及其衍生物在抗乙肝病毒中的应用
CN101250510A (zh) * 2008-03-19 2008-08-27 广东药学院 丙肝病毒特异性核酶M1GS-hcv/C20的构建方法和应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JEROME MULHBACHER等: "Therapeutic applications of ribozymes and riboswitches", 《CURRENT OPINION IN PHARMACOLOGY》 *
SANJEEV SINGWI等: "POTENTIAL NUCLEASE-BASED STRATEGIES FOR HIV GENE THERAPY", 《FRONTIERS IN BIOSCIENCE》 *
付勇等: "核糖核酸酶的抗肿瘤研究进展", 《国外医学·生理、病理科学与临床分册》 *
李红等: "脱氧核酶在病毒学中的研究和应用", 《中国兽药杂志》 *

Similar Documents

Publication Publication Date Title
WO2013039861A3 (en) Engineered nucleic acids and methods of use thereof
MX2016002586A (es) Métodos y composiciones para el tratamiento guiado por rna de infección por hiv.
WO2017058658A3 (en) Methods and compositions for rna-guided treatment of hiv infection
MX2020013395A (es) Sistemas y metodos para eliminacion de tatuajes utilizando plasma frio.
MX2015015638A (es) Metodos para diseñar celulas t altamente activas para inmunoterapia.
WO2015061294A3 (en) Use of sting agonists to treat chronic hepatitis b virus infection
MY201637A (en) Natural killer cells and ilc3 cells and uses thereof
WO2014145075A3 (en) Methods and devices for high throughpout purification
WO2012047629A3 (en) Selective removal of age-modified cells for treatment of ather0sclerosis
CL2008002966A1 (es) Compuesto tetrapeptido ceto-epoxido cristalino; sal citrato cristalina del compuesto; metodos de preparacion; compuesto intermediario cristalino; metodo de preparacion; y uso para tratar cancer, enfermedad autoinmune, afeccion relacionada con trasplante, enfermedad neurodegenerativa, afeccion asociada con fibrosis, entre otros.
MD20170014A2 (ro) Metode de tratament al infecţiilor provocate de viruşii hepatitei B şi hepatitei D
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
PH12017501300A1 (en) Novel iodophor composition and methods of use
MX2016016907A (es) Metodo para eliminar contaminantes virales de extractos pancreaticos.
PH12018500680A1 (en) System for treatment of organic waste
EA201591522A1 (ru) Лечение реакции трансплантат против хозяина у подвергаемых трансплантации пациентов
CN104306962A (zh) 利用切割酶切割病毒转录酶方法
MX2013009012A (es) Composiciones inmunogenas de bordetella bronchiseptica.
CN104306961A (zh) 利用切割酶清除潜伏休眠病毒或细菌方法
CN104306960A (zh) 一种利用切割酶治疗病毒及癌症方法
CN104306990A (zh) 一种利用切割酶治疗病毒性肝病及癌症方法
CN104306989A (zh) 一种利用切割酶治疗细菌方法
CN104383558A (zh) 一种利用切割酶治疗癌症肿瘤方法
EA201592110A1 (ru) Способ осуществления по меньшей мере одного этапа обработки убойного животного, а также режущий инструмент
CN104548075A (zh) 一种利用切割酶治疗高血压等血管疾病的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150128